OPRX - OptimizeRx Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue21,206.36312,127.4227,751.4627,220.678
Cost of Revenue8,999.6666,174.6143,411.3963,622.203
Gross Profit12,206.6975,952.8084,340.0663,598.475
Operating Expenses
Research Development----
Selling General and Administrative8,449.0416,489.1175,076.99347.927
Non Recurring----
Others---3,232.899
Total Operating Expenses20,286.06113,890.6719,282.9747,818.085
Operating Income or Loss920.302-1,763.249-1,531.512-597.407
Income from Continuing Operations
Total Other Income/Expenses Net-693.958-340.78-7.6912.267
Earnings Before Interest and Taxes920.302-1,763.249-1,531.512-597.407
Interest Expense----
Income Before Tax226.344-2,104.029-1,539.203-595.14
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops226.344-2,104.029-1,539.203-595.14
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income226.344-2,104.029-1,539.203-595.14
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares226.344-2,104.029-1,539.203-595.14